Researchers will evaluate if the drug rapamycin can reverse the negative heart changes associated with subvalvular aortic stenosis, the most common congenital heart defect in dogs.
Researchers will develop a new core vaccine that is safe and can provide superior protection against three common cat viruses, feline herpesvirus-1 (FHV-1), feline calicivirus (FCV) and feline panleukopenia virus (FPV).
Researchers will evaluate the effect of blocking a key protein involved in fat metabolism that may help improve quality of life for cats with osteoarthritis.